Jeannie Wong studied Biomedical Engineering, followed by Master of Medical Physics at the Universiti Malaya. She received her PhD from the University of Wollongong, Australia. She started her career at the Department of Biomedical Imaging, Faculty of Medicine, the University of Malaya as a senior lecturer in 2011. She coordinated the UM Master of Medical Physics programme from 2013 to 2017, which is accredited by the Institute of Physics and Engineering in Medicine (IPEM), UK. It is the only postgraduate medical physics programme outside the UK and Ireland that has this accreditation. During her PhD study, she was instrumental in the development of a new field of medical dosimetry in radiation therapy quality assurance with high spatial resolution semiconductor dosimetry and its applications in radiation therapy quality assurance. She has since further extended her research to include dosimetry in diagnostic imaging and patient-specific dosimetry. She has published more than 60 papers to date. She was promoted to associate professor in 2018. Her research interests include radiation dosimetry, radiotherapy, medical imaging and radiomics. She had supervised 1 postdoctoral candidate, 4 PhD students, 2 masters by research students, and more than 37 masters by coursework students. Dr Wong has vast experience in the teaching of physics and biostatistics at the postgraduate level. She has been involved as lecturer and examiner for the Master of Radiology and Master of Clinical Oncology at the University of Malaya since 2012. Her research interest are radiation dosimetry, medical imaging, radiotherapy and radiomics. IN 2019, she received the Southeast Asian Federation of Organizations of Medical Physics (SEAFOMP) Young Leader Award.

A social work educator with a foundation in disability studies particularly for the intellectually disabled (mental and learning category), coping mechanism, and social work case management. My academic journey has been dedicated to empowering persons with disabilities, supporting vulnerable communities, and advancing the quality of social work education in Malaysia.

Dr Sanjay Rampal was appointed Executive Director of the Department of Research Development under the Office of Deputy Vice-Chancellor (Research & Innovation), Universiti Malaya in March 2025. He is a Professor of Epidemiology and Public Health and a Public Health Physician at the Department of Social and Preventive Medicine, Faculty of Medicine, Universiti Malaya. Dr Rampal was medically trained in India and served in the Ministry of Health, Malaysia from 1998 to 2005. The clinical experiences from his early medical career helped him realize that treating one patient at a time was insufficient and that more could be done by intervening at a population level. He improved his basic epidemiology and biostatistics knowledge by completing an MPH degree in 2004 from Harvard University. He joined Universiti Malaya in 2005, intending to strengthen the research skills of the Malaysian medical and public health community. He completed his PhD in Epidemiology from Johns Hopkins University in 2014. He was Certified in Public Health (CPH) by the US National Board of Public Health Examiners in 2013. Dr Rampal’s research has focused primarily on the epidemiology and prevention of cardiovascular disease. He has investigated the etiological and prognostic roles of various factors with diabetes and cardiovascular disease. These factors include gender, ethnicity, nutrition, obesity, metabolic-associated fatty liver disease, dyslipidemia, and other structural determinants of health. He has further investigated the role of these traditional cardiovascular risk factors in cancer development. He hopes to leverage this information further to design and implement better prevention programs that reduce the number of new patients our healthcare system sees. In recent years, he has applied his epidemiological expertise to communicable diseases. He investigated the roles of Obesity and Diabetes on the prognosis of Dengue Severity. His methodological interests include improving research methodology, biostatistics, epidemiological designs, regression models, causal inference, multiple imputations, measurement error, and propensity scoring. Dr Rampal lectures in epidemiology, biostatistics, and research methods at Universiti Malaya. He has supervised 21 Doctoral, 10 4-year Master of Public Health, and 35 Master’s candidates to completion. He actively supervises 10+ postgraduate students. Since 2005, he has provided many methodological and biostatistical consultations to graduate students and clinical researchers. Dr. Rampal has published 89 WOS and 94 SCOPUS papers (h-index: 32 WOS, 39 SCOPUS; WOS Citations without Self-citations: 17,330) and supervised over 65 postgraduate students.   Dr Rampal is a Fellow of the Academy of Medicine Malaysia and was the past honorary secretary for the College of Public Health Medicine from 2006-2009 and an executive member from 2016 to 2024. He has chaired the Public Health Medicine Specialty Education Subcommittee at the Malaysian Medical Council since 2020. He was also a member of the Technical Advisory Committee for Health Technologies Economic Evaluation, Ministry of Health Malaysia, from 2017 to 2024. He had previously chaired the Malaysian National Conjoint Committee for Public Health Postgraduate Medical Program and the Public Health Society of the Malaysian Medical Association.   Dr Rampal heads the Western Pacific Regional Training Centre of the Special Programme for Research and Training in Tropical Diseases(TDR). He is also an advisory member of the Global Health Program of the Association of Pacific Rim Universities and an international advisory committee member of the ASEAN University Network Health Promotion Network. He is also a member of the International Epidemiology Association and a past member of the American Heart Association/American Stroke Association and the Society for Epidemiologic Research. During the COVID-19 pandemic, Dr Rampal improved the prevention and control of COVID-19 through active research and translation. He had actively communicated with the public through the media on COVID-19 issues. He was a member of the following committees: 1) Science and Technology Expert Panel for Disaster Risk Reduction under the Health and Emerging Threat Cluster of the Malaysia Disaster Management Agency; 2) National COVID-19 Epidemiological Analysis Task Force under the Ministry of Science, Technology, and Innovation; 3) AFC Covid-19 Advisory Expert Group; 4) UMMC COVID-19 Task Force; and 5) the Journal of Global Health Science Commission on COVID-19 Response.